AOD9604

AOD9604 is a synthetic peptide fragment derived from the C-terminus of the human growth hormone (hGH) molecule, specifically encompassing amino acids 177-191. Originally developed for its potential to treat obesity, AOD9604 is unique because it isolates the lipolytic (fat-burning) properties of natural growth hormone without the unwanted effects on blood sugar or insulin sensitivity typically associated with full-length hGH. It works by stimulating the metabolism of stored fats and inhibiting the formation of new fat cells (lipogenesis). This selective action makes it a significant subject of research in weight management and metabolic health, providing a safer alternative to traditional growth hormone therapies.

In addition to its metabolic benefits, AOD9604 has shown promising results in regenerative medicine. Research indicates that it may play a role in cartilage repair and the treatment of osteoarthritis by promoting the differentiation of mesenchymal stem cells into healthy chondrocytes. This dual action—targeting both adipose tissue reduction and structural tissue recovery—makes it a versatile tool in clinical research. The peptide is highly valued for its ability to enhance fat oxidation while maintaining a favorable metabolic profile. As a purified research compound, AOD9604 continues to be evaluated for its diverse biological effects, offering researchers a refined model to study lipid metabolism and regenerative tissue engineering.